Image de couverture de livre

Spatial-Immune Multi-omics Refines Prognostication in Early-Stage Estrogen Receptor-Positive Breast Cancer

Fuente: Zenodo

Enregistré dans:

Détails bibliographiques
Auteur principal:	Kinsella, Zak
Format:	Recurso digital
Langue:	anglais
Publié:	Zenodo 2025
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Altered Estrogen Receptor Signaling Pathway in BRCA2 ‐Deficient Estrogen Receptor‐Positive/ HER2 ‐Negative Breast Cancer
par: Kaori Kawasaki, et autres
Publié: (2026)

Significance of Estrogen/Progesterone Receptor Expression in Metaplastic Breast Carcinoma
par: Atif Ali Hashmi, et autres
Publié: (2024)

Molecular Docking Analysis of Liliaceae Family Phytochemicals to Estrogen Receptor α on Breast Cancer Compared to Genistein
par: Permana, Bryan, et autres
Publié: (2015)

A Coordinate-Based Framework in Breast Pathology for Estrogen Receptor Interpretation
par: Okubo, Takako
Publié: (2026)

Targeted Imaging of Estrogen Receptor‐Positive Cancer Cells Using Fluorescent Estradiol Probes
par: Shabnam Mansuri, et autres
Publié: (2025)

Hormone Receptors and Other Prognostic Factors in Breast Cancer in Cuba
par: Rosa Irene Álvarez Goyanes
Publié: (2010)

Effect of Estrogen Receptor on the Relationship Between HER2 Immunohistochemistry Score and Pathological Complete Response to Neoadjuvant Treatment in HER2‐Positive Breast Cancer
par: Miaomiao Jia, et autres
Publié: (2024)

Comparative Efficacy of Neoadjuvant Endocrine Therapy, Neoadjuvant Chemotherapy, and Neoadjuvant Chemo‐Endocrine Therapy in Estrogen Receptor–Positive Breast Cancer Patients: A Meta‐Analysis
par: Yi Yuan, et autres
Publié: (2025)

Correction to “Biologic Roles of Estrogen Receptor‐ β and Insulin‐Like Growth Factor‐2 in Triple‐Negative Breast Cancer”
Publié: (2026)

Prognostic and Predictive Markers for Early Stage Triple‐Negative Breast Cancer Treated With Platinum‐Based Neoadjuvant Chemotherapy
par: Zhenhui Zhao, et autres
Publié: (2024)

Estrogenic Activity of Structurally Distinct PFASs Through Estrogen Receptor Pathway
par: Fanglin Hu, et autres
Publié: (2025)

A Comprehensive Computational Approach for Identifying Estrogen Receptor Alpha Inhibitors in Breast Cancer Treatment: Integrating Biophysical Analysis and In Vitro Validation
par: Perwez Alam, et autres
Publié: (2025)

Correction: Avena et al. 27-Hydroxycholesterol Binds GPER and Induces Progression of Estrogen Receptor-Negative Breast Cancer. 2022, , 1521.
par: Avena, Paola, et autres
Publié: (2024)

Prognostic Value of Tertiary Lymphoid Structures in Primary Breast Cancer and Their Association With Immune Microenvironment
par: YunXia Xu, et autres
Publié: (2025)

Insights Into Vepdegestrant (ARV‐471): The First‐in‐Class Estrogen Receptor Proteolysis‐Targeting Chimera Approaching Food and Drug Administration Approval for Breast Cancer
par: Chao Tang, et autres
Publié: (2026)

Novel 10‐Alkoxy 1,4‐Dien‐3‐One Estranes as Multitarget Anticancer Agents Against Estrogen‐Positive Breast Cancer
par: Ivana Kuzminac, et autres
Publié: (2026)

The Immune‐Related Gene CD48 Is a Prognostic Biomarker Associated With the Breast Cancer Tumor Microenvironment
par: Yi Zhao, et autres
Publié: (2025)

Systemic Therapy Management Strategies for Early‐Stage Breast Cancer in Australia
par: Nicholas Zdenkowski, et autres
Publié: (2026)

Cubebin Niosomal Suspension Attenuates DMBA‐Induced Breast Cancer Through the Involvement of Estrogen and Progesterone Receptors and Oxidative/Inflammatory/CA 15‐3 Tumor Marker
par: Sadaf Jamal Gilani, et autres
Publié: (2026)

Estrogen‐Related Receptor Gamma (ERRγ) as Biomarker and Novel Target for Therapeutic Intervention on Cancer: A Review
par: Priyanka Upadhyay, et autres
Publié: (2024)

RETRACTION : Nutritional Flavonoids Modulate Estrogen Receptor α Signaling
Publié: (2024)

The Predictive Value of the Tumor‐Stroma Ratio for Neoadjuvant Endocrine Therapy in Hormone Receptor‐Positive Breast Cancer
par: Layla Andour, et autres
Publié: (2026)

Differential Expression of Splicing Factor Gene by Estrogen Receptor Activation Factor
par: Julie Jacob, et autres
Publié: (2025)

Practical Synthesis of Elacestrant, an FDA‐Approved Selective Estrogen Receptor Degrader
par: Chandra Shekhar, et autres
Publié: (2025)

Transfer Learning and Machine Learning for Training Five Year Survival Prognostic Models in Early Breast Cancer
par: Pilgram, Lisa, et autres
Publié: (2025)

Targeting Estrogen Receptors: A Molecular Approach to Combat Neurodegenerative Diseases
par: Debashmita Ghosh, et autres
Publié: (2026)

An Artificial Intelligence Model for Early Stage Breast Cancer Detection from Biopsy Images
par: Chaudhary, Neil, et autres
Publié: (2025)

Application of Intraoperative Radiotherapy in Early‐Stage Breast Cancer Patients in a Clinical Setting
par: Ao Wang, et autres
Publié: (2024)

YIGSR Functionalized Hybrid Exosomes Spatially Target Dasatinib to Laminin Receptors for Precision Therapy in Breast Cancer
par: Pratiksha Tiwari, et autres
Publié: (2025)

Prognostic Impact of Postoperative Recurrence in Patients With Epidermal Growth Factor Receptor–Positive Non‐Small Cell Lung Cancer
par: Meiko Morita, et autres
Publié: (2024)

Assessment of ESR1 , PGR , ERBB2 , and MKI67 mRNA in Hormone Receptor‐Positive Early Breast Cancer: A Cross‐Sectional Study
par: Hamid Rezvani, et autres
Publié: (2025)

The Prognostic Value of Worst Pattern of Invasion‐5 on Low‐Risk and Early‐Stage Oral Tongue Cancer
par: Ming‐Hsien Tsai, et autres
Publié: (2025)

Obesity and Early‐Stage Breast Cancer: A Comprehensive Analysis of Tumor Biology, Staging Accuracy, and Long‐Term Outcomes
par: Marco Yusef, et autres
Publié: (2025)

A Dyadic Analysis of Optimism, Pessimism, and Fear of Cancer Recurrence in Couples Coping With Early‐Stage Breast Cancer
par: Michael Morreale, et autres
Publié: (2025)

Quantum enhanced stratification of Breast Cancer: exploring quantum expressivity for real omics data
par: Repetto, Valeria, et autres
Publié: (2024)

Isoquercitrin Promotes Angiogenesis Through the Genomic Signaling Pathway of the Estrogen Receptor‐Alpha
par: Hai‐Xin Liu, et autres
Publié: (2025)

Investigation into the Quantitative Structure‐Biotoxicity Relationship of Antibiotics and their Estrogenic Receptor Disruption Effects
par: Wanhong Zhu, et autres
Publié: (2024)

Pembrolizumab for Early‐Stage Triple‐Negative Breast Cancer: KEYNOTE ‐522 Japan Subgroup Analysis
par: Masato Takahashi, et autres
Publié: (2026)

Landscape of the Peripheral Immune Response Induced by Intraoperative Radiotherapy Combined with Surgery in Early Breast Cancer Patients
par: Danian Dai, et autres
Publié: (2024)

Nutrient recovery technology mapping datasheet - NOVAFERT project
par: Kinsella, Dónal
Publié: (2026)